If approved, Moderna's mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across ...

The EMA's CHMP has issued a positive opinion recommending the approval of Dupixent in the EU for paediatric patients with CSU ...

BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...

The zenith of this turnaround arrived when Eli Lilly selected Lehigh Valley, an area in eastern Pennsylvania, for a new $3.5bn facility to produce the drugmaker’s forthcoming wave of weight loss ...

Novo Nordisk and Vivtex are to co-develop next-generation oral biologic therapies to treat obesity, diabetes and related ...

The organised crime group were selling unlicensed weight loss-substances online, using social media to market products.

Quotient Sciences has extended its commercial partnership with Ipsen, focusing on the production of Sohonos for FOP.

Asahi Kasei has signed a definitive agreement to acquire all issued shares of Aicuris Anti-infective Cures for approximately ...

Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.

AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...

The European Commission (EC) has approved a higher dose of Novo Nordisk’s Wegovy (semaglutide), marking a win for the ...

J&J has received the US FDA approval for a new monthly dosing schedule for the combination therapy Rybrevant Faspro to treat ...